Open help menu
On-Demand
|

Pricing

Information

Description

The goal is to enhance knowledge of aging and mental health, as well as improve clinical competence among general psychiatrists, geriatricians, advanced practice providers, social workers, nurse practitioners, psychologists, and other professionals who care for the mental health needs of older adults.

Educational Goal

To enhance participants’ knowledge and clinical competence in the use of electroconvulsive therapy (ECT) and other neurostimulation therapies in older adults by deepening their understanding of aging and mental health. This goal is aimed at general psychiatrists, geriatricians, advanced practice providers, social workers, nurse practitioners, psychologists, and other professionals involved in the mental health care of older adults.

Learning Objectives

Participants will be able to:

  • Participants will be able to cite at least three major advancements in neuromodulation made within the past five years.

  • Participants will be able to describe positive and negative predictors of response of neuromodulation in the elderl

  • Participants will be able to identify patients who will benefit the most from neuromodulation therapies

  • Participants will be able to cite recent evidence-based articles in the field of neuromodulation.

Presenters

Adriana P Hermida, MD
Dr. Adriana P. Hermida is a Professor at Emory University School of Medicine, where she leads the Geriatric Division and directs both the Geriatric Psychiatry Fellowship and Outpatient Clinic. She currently serves as President-elect of the International Psychogeriatric Association and is the immediate past President of the International Society for ECT and Neurostimulation (ISEN). Dr. Hermida has championed mentorship initiatives, such as launching the ISEN International Mentoring Trainee Award. Her excellence in teaching has been recognized with multiple honors, including the Emory Faculty Medical Student Dean’s Teaching Award and the Emory Medical School Provost Teaching Award. Her research focuses on innovative neurostimulation therapies including ECT, TMS, and ketamine for treatment-resistant depression and cognitive disorders in older adults. She has been funded by the NIMH, NIA, The Australian George Institute, and the Huntington’s Foundation, and actively contributes to multicenter trials and translational research aimed at improving cognitive tools in ECT and interventions for dementia, Parkinson’s disease, and other neuropsychiatric conditions in late life.

Financially Sponsored By

  • American Association for Geriatric Psychiatry (AAGP)